Comparison of high-flux hemodialysis with hemodialysis filtration in treatment of uraemic pruritus: a randomized controlled trial

Springer Science and Business Media LLC - Tập 48 - Trang 1533-1541 - 2016
Xia Jiang1, Fen Ji1, Zhi-Wei Chen1, Qiao-Lin Huang1
1Department of Nephrology, Center of Blood Purification, The Second People’s Hospital of Nantong, Nantong, China

Tóm tắt

Uraemic pruritus (UP) is one of the most common complications in patients with end-stage renal disease (ESRD) undergoing dialysis and greatly undermines their quality of life. The present study was designed to compare the clinical effect of high-flux hemodialysis (HFHD) with hemodialysis filtration (HDF) in the treatment of UP in ESRD patients, and to explore the possible underlying mechanisms. In this 12-week randomized and controlled trial, the clinical efficacy of HFHD or HDF on UP patients undergoing dialysis was evaluated. A total of 51 uremia patients suffering from pruritus from January 2009 to May 2013 were recruited and randomly assigned to intervention (n = 27) and control (n = 24) groups. The control group was received only HDF therapy, and the intervention group underwent HFHD treatment three times a week for 12 weeks. The scores for Visual Analogue Scale in both two groups were obviously decreased, but the Visual Analogue Scale scores in the intervention group had a better improvement than the control group within 12 weeks. The PSQI and SF-12 values in the intervention group had a better improvement than the control group within 12 weeks. In comparison of the changes from baseline between the control groups, there was greater improvement in BUN, creatinine, calcium, phosphorus, PTH, β2-MG, histamine, CRP and IL-6 levels of intervention group. Our results demonstrate that HFHD has a better efficacy in the treatment of UP than HDF. HFHD has an exactly therapeutical efficacy in the UP associated with the inhibition of microinflammation state in dialysis patients.

Tài liệu tham khảo

Nofal E, Farag F, Nofal A, Eldesouky F, Alkot R, Abdelkhalik Z (2016) Gabapentin: a promising therapy for uremic pruritus in hemodialysis patients—a randomized-controlled trial and review of literature. J Dermatol Treat. doi:10.3109/09546634.2016.1161161 Heisig M, Laczmanski L, Reich A, Lwow F, Szepietowski JC (2016) Uremic pruritus is not associated with endocannabinoid receptor 1 gene polymorphisms. Biomed Res Int. doi:10.1155/2016/3567527 Jing Y, Zhao H, Ge Y, Jia F, He Q, Wang S, Meng J (2015) Application of total parathyroidectomy with auto-transplantation for uremia secondary hyperparathyroidism treatment. Int J Clin Exp Med 8(7):11188–11194 Pisoni RL, Wikstrom B, Elder SJ, Akizawa T, Asano Y, Keen ML, Saran R, Mendelssohn DC, Young EW, Port FK (2006) Pruritus in haemodialysis patients: international results from the Dialysis Outcomes and Practice Patterns Study (DOPPS). Nephrol Dial Transplant 21(12):3495–3505. doi:10.1093/ndt/gfl461 Kim KH, Lee MS, Choi SM (2010) Acupuncture for treating uremic pruritus in patients with end-stage renal disease: a systematic review. J Pain Symp Manag 40(1):117–125 Manenti L, Tansinda P, Vaglio A (2009) Uraemic pruritus: clinical characteristics, pathophysiology and treatment. Drugs 69(3):251–263. doi:10.2165/00003495-200969030-00002 Combs SA, Teixeira JP, Germain MJ (2015) Pruritus in kidney disease. Semin Nephrol 35(4):383–391. doi:10.1016/j.semnephrol.2015.06.009 Wang H, Yosipovitch G (2010) New insights into the pathophysiology and treatment of chronic itch in patients with end-stage renal disease, chronic liver disease, and lymphoma. Int J Dermatol 49(1):1–11. doi:10.1111/j.1365-4632.2009.04249.x Ada S, Seckin D, Budakoglu I, Ozdemir FN (2005) Treatment of uremic pruritus with narrowband ultraviolet B phototherapy: an open pilot study. J Am Acad Dermatol 53(1):149–151. doi:10.1016/j.jaad.2004.12.052 Pugashetti R, Lim HW, Koo J (2010) Broadband UVB revisited: is the narrowband UVB fad limiting our therapeutic options? J Dermatol Treat 21(6):326–330. doi:10.3109/09546630903341986 Kuypers DR (2009) Skin problems in chronic kidney disease. Nat Clin Pract Nephrol 5(3):157–170. doi:10.1038/ncpneph1040 Erdem E (2015) Proton pump inhibitors use in hemodialysis patients and serum magnesium levels. Int J Clin Exp Med 8(11):21689–21693 Okano K, Kimura K, Tanaka Y, Tsuchiya K, Akiba T, Nitta K (2015) Direct measurement of reactive oxygen species in leukocytes during hemodialysis therapy. Int J Clin Exp Med 8(11):20959–20964 Liu J, Wang C, Zhao H, Zhang J, Ma J, Hou Y, Zou H (2015) Anticoagulant therapies versus heparin for the prevention of hemodialysis catheter-related complications: systematic review and meta-analysis of prospective randomized controlled trials. Int J Clin Exp Med 8(8):11985–11995 Bellien J, Freguin-Bouilland C, Joannides R, Hanoy M, Remy-Jouet I, Monteil C, Iacob M, Martin L, Renet S, Vendeville C, Godin M, Thuillez C, Le Roy F (2014) High-efficiency on-line haemodiafiltration improves conduit artery endothelial function compared with high-flux haemodialysis in end-stage renal disease patients. Nephrol Dial Transplant 29(2):414–422. doi:10.1093/ndt/gft448 Reshetnik A, Scheurig-Muenkler C, van der Giet M, Tolle M (2015) High-flux hemodialysis after administering high-dose methotrexate in a patient with posttransplant lymphoproliferative disease and impaired renal function. Clin Case Rep 3(11):932–936. doi:10.1002/ccr3.302 Cerda J, Ronco C (2009) Modalities of continuous renal replacement therapy: technical and clinical considerations. Semin Dial 22(2):114–122. doi:10.1111/j.1525-139X.2008.00549.x Wang K, Wang P, Liang XH, Yuan FF, Liu ZS (2015) Cuffed-tunneled hemodialysis catheter survival and complications in pediatric patients: a single-center data analysis in China. Int J Clin Exp Med 8(6):9765–9771 Fu X, Cui QQ, Ning JP, Fu SS, Liao XH (2015) High-flux hemodialysis benefits hemodialysis patients by reducing serum FGF-23 levels and reducing vascular calcification. Med Sci Monit Int Med J Exp Clin Res 21:3467–3473 Yue J, Jiao S, Xiao Y, Ren W, Zhao T, Meng J (2015) Comparison of pregabalin with ondansetron in treatment of uraemic pruritus in dialysis patients: a prospective, randomized, double-blind study. Int Urol Nephrol 47(1):161–167. doi:10.1007/s11255-014-0795-x Shen Q, Huang X, Luo Z, Xu X, Zhao X, He Q (2016) Sleep quality, daytime sleepiness and health-related quality-of-life in maintenance haemodialysis patients. J Int Med Res. doi:10.1177/0300060515608296 Wang SY, Zang XY, Fu SH, Bai J, Liu JD, Tian L, Feng YY, Zhao Y (2016) Factors related to fatigue in Chinese patients with end-stage renal disease receiving maintenance hemodialysis: a multi-center cross-sectional study. Ren Fail 38(3):442–450. doi:10.3109/0886022x.2016.1138819 Baum E, Pawlaczyk K, Mackowiak B, Sosinska P, Matecka M, Kolodziejczak B, Musielak M, Breborowicz A (2015) Levels of hepatocyte growth factor in serum correlate with quality of life in hemodialysis patients. Int J Clin Exp Pathol 8(10):13477–13482 Wikstrom B (2007) Itchy skin—a clinical problem for haemodialysis patients. Nephrol Dial Transplant 22(Suppl 5):v3–v7. doi:10.1093/ndt/gfm292 Ko MJ, Wu HY, Chen HY, Chiu YL, Hsu SP, Pai MF, Ju Y, Lai CF, Lu HM, Huang SC, Yang SY, Wen SY, Chiu HC, Hu FC, Peng YS, Jee SH (2013) Uremic pruritus, dialysis adequacy, and metabolic profiles in hemodialysis patients: a prospective 5-year cohort study. PLoS ONE 8(8):e71404. doi:10.1371/journal.pone.0071404 Susel J, Batycka-Baran A, Reich A, Szepietowski JC (2014) Uraemic pruritus markedly affects the quality of life and depressive symptoms in haemodialysis patients with end-stage renal disease. Acta Dermato Venereol 94(3):276–281. doi:10.2340/00015555-1749 Goh JH, Lee SY, Ooi ST, LeeSoon UL, Hee KH, Renaud CJ (2016) Post-hemodialysis dosing of 1 vs. 2 g of ceftazidime in anuric end-stage renal disease patients on low-flux dialysis and its pharmacodynamic implications on clinical use. Hemodial Int 20(2):253–260. doi:10.1111/hdi.12377 Penne EL, van der Weerd NC, Blankestijn PJ, van den Dorpel MA, Grooteman MP, Nube MJ, Ter Wee PM, Levesque R, Bots ML (2010) Role of residual kidney function and convective volume on change in β2-microglobulin levels in hemodiafiltration patients. Clin J Am Soc Nephrol CJASN 5(1):80–86. doi:10.2215/cjn.03340509 Zhang D, Sun XF, Ma ZF, Zhu HY, Wang YD, Chen XM (2011) Effects of high-flux hemodialysis on plasma adrenomedullin and sustained hypotension in elderly hemodialysis patients. Chin Med J 124(6):907–910 Kreusser W, Reiermann S, Vogelbusch G, Bartual J, Schulze-Lohoff E (2010) Effect of different synthetic membranes on laboratory parameters and survival in chronic haemodialysis patients. NDT Plus 3(Suppl 1):i12–i19. doi:10.1093/ndtplus/sfq032 Kristo I, Stift A, Staud C, Kainz A, Bachleitner-Hofmann T, Chitsabesan P, Riss S (2016) The type of loose seton for complex anal fistula is essential to improve perianal comfort and quality of life. Colorectal Dis. doi:10.1111/codi.13335 Kidir V, Altuntas A, Inal S, Akpinar A, Orhan H, Sezer MT (2015) Sexual dysfunction in dialysis patients: does vitamin D deficiency have a role? Int J Clin Exp Med 8(12):22491–22496 Kaya T, Acar BA, Sipahi S, Cinemre H, Acar T, Varim C, Tamer A (2015) Relationships between malnutrition, inflammation, sleep quality, and restless legs syndrome in hemodialysis patients. Ther Apheresis Dial 19(5):497–502. doi:10.1111/1744-9987.12313 Slinin Y, Greer N, Ishani A, MacDonald R, Olson C, Rutks I, Wilt TJ (2015) Timing of dialysis initiation, duration and frequency of hemodialysis sessions, and membrane flux: a systematic review for a KDOQI clinical practice guideline. Am J Kidney Dis 66(5):823–836. doi:10.1053/j.ajkd.2014.11.031 Khan TM, Al-Haider I, Syed Sulaiman SA, Hassali MA (2013) Linguistic validation of the 5D itching scale to Arabic in patients with end-stage kidney disease. J Ren Care 39(4):222–227. doi:10.1111/j.1755-6686.2013.12038.x Steubl D, Roos M, Hettwer S, Satanovskij R, Tholen S, Wen M, Schmaderer C, Hasenau AL, Luppa P, Stecher L, Heemann U, Renders L (2016) Plasma total C-terminal agrin fragment (tCAF) as a marker for kidney function in patients with chronic kidney disease. Clin Chem Lab Med. doi:10.1515/cclm-2015-1027 Xu C, Li YC, Zhao SM, Li ZX (2016) Evaluation of responses to vitamin D3 (cholecalciferol) in patients on dialysis: a systematic review and meta-analysis. J Investig Med. doi:10.1136/jim-2015-000032 Chen ZJ, Cao G, Tang WX, Lv XY, Huang SM, Qin W, Ping F, Ye T (2009) A randomized controlled trial of high-permeability haemodialysis against conventional haemodialysis in the treatment of uraemic pruritus. Clin Exp Dermatol 34(6):679–683. doi:10.1111/j.1365-2230.2008.03075.x Kimmel M, Alscher DM, Dunst R, Braun N, Machleidt C, Kiefer T, Stulten C, van der Kuip H, Pauli-Magnus C, Raub U, Kuhlmann U, Mettang T (2006) The role of micro-inflammation in the pathogenesis of uraemic pruritus in haemodialysis patients. Nephrol Dial Transplant 21(3):749–755. doi:10.1093/ndt/gfi204 Peer G, Kivity S, Agami O, Fireman E, Silverberg D, Blum M, Laina A (1996) Randomised crossover trial of naltrexone in uraemic pruritus. Lancet (Lond, Engl) 348(9041):1552–1554 Jia P, Jin W, Teng J, Zhang H, Zou J, Liu Z, Shen B, Cao X, Ding X (2016) Acute effects of hemodiafiltration versus conventional hemodialysis on endothelial function and inflammation: a randomized crossover study. Medicine 95(16):e3440. doi:10.1097/md.0000000000003440 Lin HH, Liu YL, Liu JH, Chou CY, Yang YF, Kuo HL, Huang CC (2008) Uremic pruritus, cytokines, and polymethylmethacrylate artificial kidney. Artif Organs 32(6):468–472. doi:10.1111/j.1525-1594.2008.00568.x